1. 1. World Health Organization (WHO). Guidelines for intensified tuberculosis case-finding and preventive therapy for people living with HIV in resource-constrained settings. 2011. Geneva, Switzerland. Available at <http://apps.who.int/iris/bitstream/10665/44472/1/9789241500708_eng.pdf>. Accessed June 1, 2016.
2. 2. Cattamanchi A, Smith R, Steingart KR, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2011;56:230-8.
3. 3. Akolo C, Adetifa I, Shepperd S, et al. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010;1:CD000171.
4. 4. Mazurek GH, Jereb J, Vernon A, et al. Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection–United States, 2010. MMWR Recomm Rep. 2010;59:1-25.
5. 5. Khawcharoenporn T, Apisarnthanarak A, Sungkanuparph S, et al. Tuberculin skin test and isoniazid prophylaxis among health care workers in high tuberculosis prevalence areas. Int J Tuberc Lung Dis. 2011;15:14-23.